Worldwide Dyslipidemia Guidelines-Reference-Cited by-同舟云学术

Worldwide Dyslipidemia Guidelines

Published:2019-01-25 Issue:2 Volume:13 Page:
ISSN:1932-9520
Container-title:Current Cardiovascular Risk Reports
language:en
Short-container-title:Curr Cardiovasc Risk Rep

Author:

Bartlomiejczyk Marcin Adam,Penson Peter,Banach Maciej

Funder

The Medical University of Lodz

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s12170-019-0597-x/fulltext.html

Reference34 articles.

1. Field MJ, Lohr KN. Guidelines for clinical practice: from development to use. Washington, D.C: Institute of Medicine, National Academy Press; 1992.

2. Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ. 1995;310(6987):1122–6.

3. Martin SS, Sperling LS, Blaha MJ, Wilson PWF, Gluckman TJ, Blumenthal RS, et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA guidelines. J Am Coll Cardiol. 2015;65(13):1361–8.

4. Morris PB, McLain K. What the guidelines do not say: statin non-benefit groups. Curr Atheroscler Rep. 2015;17(1):468.

5. •• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934 Currently available guidelines for managing dyslipidemia in the USA.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for cardiovascular disease risk reduction: a systematic review and an appraisal through AGREE II and AGREE REX tools;Family Practice;2024-06-04

2. Effect of aluminium on lipid profile and atherogenic index in prepubertal and young adult female rats: A pilot study;Indian Journal of Physiology and Pharmacology;2023-07-01

3. DiDang decoction improves mitochondrial function and lipid metabolism via the HIF-1 signaling pathway to treat atherosclerosis and hyperlipidemia;Journal of Ethnopharmacology;2023-05

4. The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines;Journal of Cardiovascular and Thoracic Research;2023-03-16

5. Major Global Coronary Artery Calcium Guidelines;JACC: Cardiovascular Imaging;2023-01